In light of this study, we suggest that the oncogenic role of AurkA in breast cancers is not only depending by its key role during mitosis, but may include its capacity to control the “hard-core” of the tumor, that is the BCICs in the inner mass which account for response to cancer therapies, metastatic spread and recurrence. Here, AURKA is linked to breast cancer.